Plasma natriuretic peptides relate to distinct patterns of left ventricular dysfunction in chronic heart failure with preserved ejection fraction

26 May 2018 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Elisa Dal Canto

University Medical Center Utrecht, Utrecht (Netherlands (The))

25 More presentations in this session

Presentation thumbnail

Safety and tolerability of a first in class chymase inhibitor in clinically stable patients with left-ventricular dysfunction after myocardial infarction

Professor M. Senni (Bergamo, IT)

Presentation thumbnail

The relations between pro- and anti-inflammatory cytokines contractile ability of the myocardium in patients with coronary artery disease

Presentation thumbnail

Predictors of galectin-3 in patients with heart failure and reduced ejection fraction

Doctor I. Alexanian (Athens, GR)

Presentation thumbnail

The role of Response-to-Diuretic in predicting prognosis in discharged heart failure patients after an acute decompensation.

Doctor M. Feola (Mondovi, IT)

Presentation thumbnail

Mobile cardiopaging in toxic cardiomyopathy diagnostics in cancer patients

Professor N. Lyamina (Moscow, RU)

Access the full session

Session thumbnail

Poster Session 4 - Chronic Heart Failure – Pathophysiology and Mechanisms

The Event

Heart Failure 2018

26 May - 29 May 2018

You may be interested in

Congress Presentation

Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.

Congress Presentation

Pharmacotherapy in HFpEF: where do cardiometabolic drugs fit in?

Congress Session

Clinical phenotypes of heart failure with preserved ejection fraction

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources